Immunological role of progesterone in the maintenance of pregnancy;Papel inmunológico de la progesterona en el mantenimiento del embarazo

Revista de Investigacion Clinica

Volumn 59, Issue 2, 2007, Pages 139-145

  Barrera, David ^a   Avila, Euclides ^a   Díaz, Lorenza ^a  

^a INSTITUTO NACIONAL DE CIENCIAS MÉDICAS Y NUTRICIÓN SALVADOR ZUBIRÁN   (Mexico)

Author keywords

Calcineurin; Cytokines; NF kB; Progesterone; T lymphocytes; Trophoblast

Indexed keywords

CALCINEURIN; CELL RECEPTOR; CHORIONIC GONADOTROPIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 4; INTERLEUKIN 6; PROGESTERONE;

CELLULAR IMMUNITY; CYTOKINE RELEASE; FETOPLACENTAL UNIT; HORMONE ACTION; HORMONE BINDING; HORMONE RECEPTOR INTERACTION; HUMAN; IMMUNE DEFICIENCY; IMMUNOLOGY; NIDATION; PLACENTA DEVELOPMENT; PREGNANCY; PROTEIN EXPRESSION; REGULATORY MECHANISM; REVIEW; T LYMPHOCYTE; TH2 CELL; TROPHOBLAST;

EID: 34447280865     PISSN: 00348376     EISSN: 00348376     Source Type: Journal    
DOI: None     Document Type: Review

References (49)

1. Albrecht ED, Pepe GJ. Placental steroid hormone biosynthesis in primate pregnancy. Endocr Rev 1990; 11: 124-50.
2. Diczfalusy E. Steroid metabolism in the human foeto-placental unit. Acta Endocrinol (Copenh) 1969; 61: 649-64.
3. Ragusa A, de Carolis C, dal Lago A, Miriello D, Ruggiero G, Brucato A, et al. Progesterone supplement in pregnancy: an immunologic therapy? Lupus 2004; 13: 639-42.
4. Astle S, Slater DM, Thornton S. The involvement of progesterone in the onset of human labour. Eur J Obstet Gynecol Reprod Biol 2003; 108: 177-81.
5. Weiss G. Endocrinology of parturition. J Clin Endocrinol Metab 2000; 85: 4421-5.
6. Auboeuf D, Dowhan DH, Dutertre M, Martin N, Berget SM, O'Malley BW. A subset of nuclear receptor coregulators act as coupling proteins during synthesis and maturation of RNA transcripts. Mol Cell Biol 2005; 25: 5307-16.
7. Bain DL, Heneghan AF, Connaghan-Jones KD, Miura MT. Nuclear receptor structure: implications for function. Annu Rev Physiol 2007; 69: 201-20.
8. Conneely OM, Mulac-Jericevic B, Lydon JP. Progesterone-dependent regulation of female reproductive activity by two distinct progesterone receptor isoforms. Steroids 2003; 68: 771-8.
9. Bramley T. Non-genomic progesterone receptors in the mammalian ovary: some unresolved issues. Reproduction 2003; 125: 3-15.
10. Mulac-Jericevic B, Conneely OM. Reproductive tissue selective actions of progesterone receptors. Reproduction 2004; 128: 139-46.
11. Lange CA. Making sense of cross-talk between steroid hormone receptors and intracellular signaling pathways: who will have the last word? Mol Endocrinol 2004; 18: 269-78.
12. Ballare C, Vallejo G, Vicent GP, Saragueta P, Beato M. Progesterone signaling in breast and endometrium. J Steroid Biochem Mol Biol 2006; 102: 2-10.
13. Vallejo G, Ballare C, Baranao JL, Beato M, Saragueta P. Progestin activation of nongenomic pathways via cross talk of progesterone receptor with estrogen receptor beta induces proliferation of endometrial stromal cells. Mol Endocrinol 2005; 19: 3023-37.
14. Faivre EJ, Lange CA. Progesterone Receptors upregulate Wnt-1 to Induce epidermal growth factor receptor transactivation and c-Src-dependent sustained activation of Erk1/2 Mitogen-activated protein kinase in breast cancer cells. Mol Cell Biol 2007; 27: 466-80.
15. Dey SK, Lim H, Das SK, Reese J, Paria BC, Daikoku T, et al. Molecular cues to implantation. Endocr Rev 2004; 25: 341-73.
16. Lee KY, DeMayo FJ. Animal models of implantation. Reproduction 2004; 128: 679-95.
17. Peltier MR. Immunology of term and preterm labor. Reprod Biol Endocrinol 2003; 1: 122.
18. Piccinni MP, Romagnani S. Regulation of fetal allograft survival by a hormone-controlled Th1- and Th2-type cytokines. Immunol Res 1996; 15: 141-50.
19. Piccinni MP. T cells in normal pregnancy and recurrent pregnancy loss. Reprod Biomed Online 2006; 13: 840-4.
20. Szekeres-Bartho J, Polgar B, Kozma N, Miko E, Par G, Szereday L, et al. Progesterone-dependent immunomodulation. Chem Immunol Allergy 2005; 89: 118-25.
21. Par G, Geli J, Kozma N, Varga P, Szekeres-Bartho J. Progesterone regulates IL12 expression in pregnancy lymphocytes by inhibiting phospholipase A2. Am J Reprod Immunol 2003; 49: 1-5.
22. Druckmann R, Druckmann MA. Progesterone and the immunology of pregnancy. J Steroid Biochem Mol Biol 2005; 97: 389-96.
23. Joachim R, Zenclussen AC, Polgar B, Douglas AJ, Fest S, Knackstedt M, et al. The progesterone derivative dydrogesterone abrogates murine stress-triggered abortion by inducing a Th2 biased local immune response. Steroids 2003; 68: 931-40.
24. Salomon LJ, Rozenberg P, Szekeres-Bartho J, Malagrida L, Giudicelli Y, Ville Y. Changes in progesterone-induced-blocking-factor expression rates following mifepristone administration in termination of pregnancy at 5 to 8 weeks. J Matern Fetal Neonatal Med 2005; 17: 353-6.
25. Murphy KM, Reiner SL. The lineage decisions of helper T cells. Nat Rev Immunol 2002; 2: 933-44.
26. Kozma N, Halasz M, Polgar B, Poehlmann TG, Markert UR, Palkovics T, et al. Progesterone-induced blocking factor activates STAT6 via binding to a novel IL-4 receptor. J Immunol 2006; 176: 819-26.
27. Kozma N, Halasz M, Palkovics T, Szekeres-Bartho J. The progesterone-induced blocking factor modulates the balance of PKC and intracellular Ca. Am J Reprod Immunol 2006; 55: 122-9.
28. Kelly RW, King AE, Critchley HO. Cytokine control in human endometrium. Reproduction 2001; 121: 3-19.
29. Wissink S, van Heerde EC, vand der Burg B, van der Saag PT. A dual mechanism mediates repression of NF-kappaB activity by glucocorticoids. Mol Endocrinol 1998; 12: 355-63.
30. McKay LI, Cidlowski JA. Molecular control of immune/inflammatory responses: interactions between nuclear factor-kappa B and steroid receptor-signaling pathways. Endocr Rev 1999; 20: 435-59.
31. Losel RM, Falkenstein E, Feuring M, Schultz A, Tillmann HC, Rossol-Haseroth K, et al. Nongenomic steroid action: controversies, questions, and answers. Physiol Rev 2003; 83: 965-1016.
32. Ehring GR, Kerschbaum HH, Eder C, Neben AL, Fanger CM, Khoury RM, et al. A nongenomic mechanism for progesterone-mediated immunosuppression: inhibition of K+ channels, Ca2+ signaling, and gene expression in T lymphocytes. J Exp Med 1998; 188: 1593-602.
33. Simoncini T, Genazzani AR. Non-genomic actions of sex steroid hormones. Eur J Endocrinol 2003; 148: 281-92.
34. Tato CM, O'Shea JJ. Immunology: what does it mean to be just 17? Nature 2006; 441: 166-8.
35. Pongcharoen S, Somran J, Sritippayawan S, Niumsup P, Chanchan P, Butkhamchot P, et al. Interleukin-17 expression in the human placenta. Placenta 2007; 28: 59-63.
36. Pongcharoen S, Niumsup P, Sanguansermsri D, Supalap K, Butkhamchot P. The effect of interleukin-17 on the proliferation and invasion of JEG-3 human choriocarcinoma cells. Am J Reprod Immunol 2006; 55: 291-300.
37. Mangan PR, Harrington LE, O'Quinn DB, Helms WS, Bullard DC, Elson CO, et al. Transforming growth factor-beta induces development of the T(H)17 lineage. Nature 2006; 441: 231-4.
38. Bettelli E, Carrier Y, Gao W, Korn T, Strom TB, Oukka M, et al. Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells. Nature 2006; 441: 235-8.
39. Kleinschek MA, Owyang AM, Joyce-Shaikh B, Langrish CL, Chen Y, Gorman DM, et al. IL-25 regulates Th17 function in autoimmune inflammation. J Exp Med 2007; 204(1): 161-70.
40. Robertson SA, Seamark RF, Guilbert LJ, Wegmann TG. The role of cytokines in gestation. Crit Rev Immunol 1994; 14: 239-92.
41. Bowen JM, Chamley L, Mitchell MD, Keelan JA. Cytokines of the placenta and extra-placental membranes: biosynthesis, secretion and roles in establishment of pregnancy in women. Placenta 2002; 23: 239-56.
42. Rein DT, Breidenbach M, Honscheid B, Friebe-Hoffmann U, Engel H, Gohring UJ, et al. Preeclamptic women are deficient of interleukin-10 as assessed by cytokine release of trophoblast cells in vitro. Cytokine 2003; 23: 119-25.
43. Piccinni MP. T-cell cytokines in pregnancy. Am J Reprod Immunol 2002; 47: 289-94.
44. Oh SY, Kim CJ, Park I, Romero R, Sohn YK, Moon KC, et al. Progesterone receptor isoform (A/B) ratio of human fetal membranes increases during term parturition. Am J Obstet Gynecol 2005; 193: 1156-60.
45. Goldman S, Weiss A, Almalah I, Shalev E. Progesterone receptor expression in human decidua and fetal membranes before and after contractions: possible mechanism for functional progesterone withdrawal. Mol Hum Reprod 2005; 11: 269-77.
46. Taylor AH, McParland PC, Taylor DJ, Bell SC. The progesterone receptor in human term amniochorion and placenta is isoform C. Endocrinology 2006; 147: 687-93.
47. Staeva-Vieira TP, Freedman LP. 1,25-dihydroxyvitamin D3 inhibits IFN-gamma and IL-4 levels during in vitro polarization of primary murine CD4+ T cells. J Immunol 2002; 168: 1181-9.
48. Evans KN, Bulmer JN, Kilby MD, Hewison M. Vitamin D and placental-decidual function. J Soc Gynecol Investig 2004; 11: 263-71.
49. Saito S. Cytokine network at the feto-maternal interface. J Reprod Immunol 2000; 47: 87-103.